Redhill Biopharma
RDHL
#11160
Rank
C$3.58 M
Marketcap
C$0.40
Share price
-13.08%
Change (1 day)
-72.50%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: C$3.58 Million

As of November 2026 Redhill Biopharma has a market cap of C$3.58 Million. This makes Redhill Biopharma the world's 11160th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.58 M-54.95%
2025C$7.95 M-37.39%
2024C$12.69 M-66.67%
2023C$38.09 M119.42%
2022C$17.36 M-89.92%
2021C$0.17 B-55.63%
2020C$0.38 B38.89%
2019C$0.27 B30.37%
2018C$0.21 B56.01%
2017C$0.13 B-42.67%
2016C$0.23 B5.58%
2015C$0.22 B67.06%
2014C$0.13 B68.06%
2013C$80.89 M

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Redhill Biopharma was reported to be:

C$3.32 Million
by Nasdaq info icon info icon
C$3.58 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
C$160.18 B 4,472,658.54%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$472.72 B 13,199,528.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$137.28 B 3,833,165.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$65.64 B 1,832,762.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
C$2.31 B 64,566.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel